Targeting Marek's disease virus by RNA interference delivered from a herpesvirus vaccine

Vaccine

Volumn 27, Issue 2, 2009, Pages 298-306

  Lambeth, Luke S ^a   Zhao, Yuguang ^a   Smith, Lorraine P ^a   Kgosana, Lydia ^a   Nair, Venugopal ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

Herpesvirus of turkeys; Marek's disease virus; RNA interference

Indexed keywords

HERPES VACCINE; LIVE VACCINE; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE SILENCING; GENETIC ENGINEERING; INFECTION CONTROL; MARDIVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; BASE SEQUENCE; CHICKENS; DNA-BINDING PROTEINS; HERPESVIRUS 1, MELEAGRID; HERPESVIRUS 2, GALLID; MAREK DISEASE; MAREK DISEASE VACCINES; MOLECULAR SEQUENCE DATA; POULTRY DISEASES; RECOMBINATION, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 57149115125     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.023     Document Type: Article

References (54)

1. ICTVdB-Management. 00.031.1. 03. Mardivirus. In: Búchen-Osmond C. (Ed). ICTVdB-the universal virus database, version 4 (2006), Columbia University, New York, USA
2. Marek J. Multiple Nervenentzuendung (Polyneuritis) bei Huehnern. Dtsch Tierarztl Wochenschr 15 (1907) 417-421
3. Gimeno I.M., Witter R.L., Hunt H.D., Reddy S.M., and Neumann U. Differential attenuation of the induction by Marek's disease virus of transient paralysis and persistent neurological disease: a model for pathogenesis studies. Avian Pathol 30 (2001) 397-410
4. Witter R.L. Increased virulence of Marek's disease virus field isolates. Avian Dis 41 1 (1997 Jan-Mar) 149-163
5. Witter R.L. Protective efficacy of Marek's disease vaccines. In: Hirai K. (Ed). Current topics in microbiology and immunology (2001), Springer, Berlin 57-90
6. Witter R.L. Marek's disease: the continuing struggle between pathogen and host. Vet J 170 2 (2005 Sep) 149-150
7. Rispens B.H., VanVloten H.J., Mastenbroek N., Maas H.J.L., and Schat K.A. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI988) and its use in laboratory vaccination trials. Avian Dis 16 (1972) 108-125
8. Witter R.L. Safety and comparative efficacy of the CVI988/Rispens vaccine strain. In: de Boer G., and Jeurissen S.H.M. (Eds). Proceedings of the 4th international symposium on Marek's disease. Wageningen, Amsterdam (1992), Ponsen & Looijen, The Netherlands 315-319
9. Witter R.L. Marek's disease vaccines-past, present and future (Chicken vs. virus-a battle of the centuries). In: Schat K.A., Morgan R.W., Parcells M.S., and Spencer J.L. (Eds). Current progress on Marek's disease research (2001), American Association of Avian Pathologists, Kennett Square, PA 1-9
10. Nair V. Successful control of Marek's disease by vaccination. Dev Biol (Basel) 119 (2004) 147-154
11. Davison F., and Nair V. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?. Expert Rev Vaccines 4 1 (2005 Feb) 77-88
12. Nair V. Evolution of Marek's disease-a paradigm for incessant race between the pathogen and the host. Vet J 170 2 (2005 Sep) 175-183
13. Hannon G.J. RNA interference. Nature 418 July (6894) (2002) 244-251
14. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu Rev Biochem 67 (1998) 227-264
15. Williams B.R. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. Biochem Soc Trans 25 May (2) (1997) 509-513
16. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 May (6836) (2001) 494-498
17. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 April (5567) (2002) 550-553
18. Yu J.Y., DeRuiter S.L., and Turner D.L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99 April (9) (2002) 6047-6052
19. Domitrovich A.M., and Kunkel G.R. Multiple, dispersed human U6 small nuclear RNA genes with varied transcriptional efficiencies. Nucleic Acids Res 31 May (9) (2003) 2344-2352
20. Kudo T., and Sutou S. Usage of putative chicken U6 promoters for vector-based RNA interference. J Reprod Dev 51 June (3) (2005) 411-417
21. Wise T.G., Schafer D.J., Lambeth L.S., Tyack S.G., Bruce M.P., Moore R.J., et al. Characterization and comparison of chicken U6 promoters for the expression of short hairpin RNAs. Anim Biotechnol 18 3 (2007) 153-162
22. Lambeth L.S., Wise T.G., Moore R.J., Muralitharan M.S., and Doran T.J. Comparison of bovine RNA polymerase III promoters for short hairpin RNA expression. Anim Genet 37 August (4) (2006) 369-372
23. Randall G., and Rice C.M. Interfering with hepatitis C virus RNA replication. Virus Res 102 June (1) (2004) 19-25
24. Coburn G.A., and Cullen B.R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 76 September (18) (2002) 9225-9231
25. Ge Q., McManus M.T., Nguyen T., Shen C.H., Sharp P.A., Eisen H.N., et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 100 March (5) (2003) 2718-2723
26. Chen W., Yan W., Du Q., Fei L., Liu M., Ni Z., et al. RNA interference targeting VP1 inhibits foot-and-mouth disease virus replication in BHK-21 cells and suckling mice. J Virol 78 July (13) (2004) 6900-6907
27. Liu M., Chen W., Ni Z., Yan W., Fei L., Jiao Y., et al. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome. Virology 336 May (1) (2005) 51-59
28. Jia Q., and Sun R. Inhibition of gammaherpesvirus replication by RNA interference. J Virol 77 March (5) (2003) 3301-3306
29. Chang Y., Chang S.S., Lee H.H., Doong S.L., Takada K., and Tsai C.H. Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference. J Gen Virol 85 June (Pt 6) (2004) 1371-1379
30. Bhuyan P.K., Kariko K., Capodici J., Lubinski J., Hook L.M., Friedman H.M., et al. Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes. J Virol 78 October (19) (2004) 10276-10281
31. Yoon J.S., Kim S.H., Shin M.C., Hong S.K., Jung Y.T., Khang I.G., et al. Inhibition of herpesvirus-6B RNA replication by short interference RNAs. J Biochem Mol Biol 37 May (3) (2004) 383-385
32. Wiebusch L., Truss M., and Hagemeier C. Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gen Virol 85 January (Pt 1) (2004) 179-184
33. Godfrey A., Anderson J., Papanastasiou A., Takeuchi Y., and Boshoff C. Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 105 March (6) (2005) 2510-2518
34. Mallanna S.K., Rasool T.J., Sahay B., Aleyas A.G., Ram H., Mondal B., et al. Inhibition of Anatid Herpes Virus-1 replication by small interfering RNAs in cell culture system. Virus Res 115 February (2) (2006) 192-197
35. Palliser D., Chowdhury D., Wang Q.Y., Lee S.J., Bronson R.T., Knipe D.M., et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439 January (7072) (2006) 89-94
36. Schumacher D., Tischer B.K., Fuchs W., and Osterrieder N. Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J Virol 74 December (23) (2000) 11088-11098
37. Himly M., Foster D.N., Bottoli I., Iacovoni J.S., and Vogt P.K. The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses. Virology 248 September (2) (1998) 295-304
38. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., et al. Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. J Virol 78 December (23) (2004) 13376-13380
39. Smith E.J., Fadly A., and Okazaki W. An enzyme-linked immunosorbent assay for detecting avian leukosis-sarcoma viruses. Avian Dis 23 July-September (3) (1979) 698-707
40. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., et al. Identification of microRNAs of the herpesvirus family. Nat Methods 2 April (4) (2005) 269-276
41. Baigent S.J., Petherbridge L.J., Howes K., Smith L.P., Currie R.J., and Nair V.K. Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. J Virol Methods 123 January (1) (2005) 53-64
42. Boden D., Pusch O., Silbermann R., Lee F., Tucker L., and Ramratnam B. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins. Nucleic Acids Res 32 3 (2004) 1154-1158
43. Bron R., Eickholt B.J., Vermeren M., Fragale N., and Cohen J. Functional knockdown of neuropilin-1 in the developing chick nervous system by siRNA hairpins phenocopies genetic ablation in the mouse. Dev Dyn 230 June (2) (2004) 299-308
44. Harpavat S., and Cepko C.L. RCAS-RNAi: a loss-of-function method for the developing chick retina. BMC Dev Biol 6 (2006) 2
45. Baigent S.J., Petherbridge L.J., Smith L.P., Zhao Y., Chesters P.M., and Nair V.K. Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease. J Gen Virol 87 April (Pt 4) (2006) 769-776
46. Gimeno I.M. Marek's disease vaccines: a solution for today but a worry for tomorrow?. Vaccine 26 July (Suppl. 3) (2008) C31-C41
47. Li L., Lin X., Khvorova A., Fesik S.W., and Shen Y. Defining the optimal parameters for hairpin-based knockdown constructs. RNA 13 October (10) (2007) 1765-1774
48. McIntyre G.J., and Fanning G.C. Design and cloning strategies for constructing shRNA expression vectors. BMC Biotechnol 6 (2006) 1
49. Federspiel M.J., and Hughes S.H. Retroviral gene delivery. Methods Cell Biol 52 (1997) 179-214
50. Petropoulos C.J., and Hughes S.H. Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells. J Virol 65 July (7) (1991) 3728-3737
51. Saydam O., Glauser D.L., Heid I., Turkeri G., Hilbe M., Jacobs A.H., et al. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Mol Ther 12 November (5) (2005) 803-812
52. Hong C.S., Goins W.F., Goss J.R., Burton E.A., and Glorioso J.C. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo. Gene Ther 13 July (14) (2006) 1068-1079
53. Calnek B.W., Carlisle J.C., Fabricant J., Murthy K.K., and Schat K.A. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. Am J Vet Res 40 April (4) (1979) 541-548
54. Fabricant J., Calnek B.W., and Schat K.A. The early pathogenesis of turkey herpesvirus infection in chickens and turkeys. Avian Dis 26 April-June (2) (1982) 257-264